Medical condition
Ipf
Ipf is a medical condition tracked by NovaPharmaNews across 3 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- pirfenidone (ARX-PIRFENIDONE) Antineoplastic and immunomodulating agents (L04)
- nintedanib (OFEV) Antineoplastic and immunomodulating agents (L01)
- nerandomilast (JASCAYD)
Latest Ipf news
Acceleron and Westlake Launch New IPF Biotech Venture
Acceleron and Westlake are initiating a new biotech focused on idiopathic pulmonary fibrosis (IPF). This article explores the implications for the pharmaceutical industry.
Addex Therapeutics GABAB PAM Shows Promise for IPF-Related Chronic Cough in Preclinical Study
Addex Therapeutics reports positive preclinical data for its GABAB PAM candidate treating chronic cough in idiopathic pulmonary fibrosis patients.